Authors:
Mourad, G
Garrigue, V
Squifflet, JP
Besse, T
Berthoux, F
Alamartine, E
Durand, D
Rostaing, L
Lang, P
Baron, C
Glotz, D
Antoine, C
Vialtel, P
Romanet, T
Lebranchu, Y
Al Najjar, A
Hiesse, C
Potaux, L
Merville, P
Touraine, JL
Lefrancois, N
Kessler, M
Renoult, E
Pouteil-Noble, C
Cahen, R
Legendre, C
Bedrossian, J
Le Pogamp, P
Rivalan, J
Olmer, M
Purgus, R
Mignon, F
Viron, B
Charpentier, B
Citation: G. Mourad et al., Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression, TRANSPLANT, 72(6), 2001, pp. 1050-1055
Authors:
Halimi, JM
Al-Najjar, A
Buchler, M
Giraudeau, B
Etienne, I
Picou, S
Marliere, J
Nivet, H
Lebranchu, Y
Citation: Jm. Halimi et al., Microalbuminuria in hypertensive non-proteinuric renal transplant recipients: Role of previous acute rejection episodes and sodium intake, ARCH MAL C, 94(8), 2001, pp. 933-936
Citation: Jm. Halimi et Y. Lebranchu, Regulation and dysfunction of endothelium-dependant vasomotricity: applications in clinical practice, PRESSE MED, 29(38), 2000, pp. 2109-2115
Authors:
Halimi, JM
Giraudeau, B
Vol, S
Caces, E
Nivet, H
Lebranchu, Y
Tichet, J
Citation: Jm. Halimi et al., Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population, KIDNEY INT, 58(3), 2000, pp. 1285-1292
Authors:
Cappellesso, S
Thibault, G
Hoarau, C
Watier, H
Bardos, P
Lebranchu, Y
Citation: S. Cappellesso et al., Induction of Jurkat T-cell apoptosis by Fas ligand-transfected endothelialcells, TRANSPLAN P, 32(8), 2000, pp. 2737-2738
Authors:
de Ligny, BH
Etienne, I
Francois, A
Toupance, O
Buchler, M
Touchard, G
Lepogamp, P
Comoz, F
Lobbedez, T
Godin, M
Ryckelynck, JP
Lebranchu, Y
Citation: Bh. De Ligny et al., Polyomavirus-induced acute tubulo-interstitial nephritis in renal allograft recipients, TRANSPLAN P, 32(8), 2000, pp. 2760-2761
Authors:
Francois, M
Buchler, M
Halimi, JM
Al-Najjar, A
Valentin, JF
Thibault, G
Lebranchu, Y
Citation: M. Francois et al., Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil, TRANSPLAN P, 32(8), 2000, pp. 2781-2782
Citation: Bh. De Ligny et Y. Lebranchu, The use of thymoglobuline induction in renal transplantation: A pharmacovigilance study, TRANSPLAN P, 32(2), 2000, pp. 351-352
Authors:
Camara, NOS
Cappellesso, S
Watier, H
Lebranchu, Y
Citation: Nos. Camara et al., Endothelial cells provide costimulatory signals to trigger both allogeneicadult and cord blood (NAIVE) CD4+T-cell proliferation, TRANSPLAN P, 32(2), 2000, pp. 355-356
Authors:
Lebranchu, Y
Aubert, P
Bayle, F
Bedrossian, J
Berthoux, F
Bourbigot, B
Buchler, M
Chalopin, JM
Deteix, P
Glotz, D
De Ligny, BH
Kessler, M
Lang, P
Lefrancois, N
Le Pogamp, P
Moulin, B
Mourad, G
Olmer, M
Sraer, JD
Touchard, G
Toupance, O
Wolf, P
Puget, S
Citation: Y. Lebranchu et al., Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids, TRANSPLAN P, 32(2), 2000, pp. 396-397
Authors:
Thervet, E
Charpentier, B
Durand, D
Glotz, D
Lebranchu, Y
Lefrancois, N
Wolf, P
Citation: E. Thervet et al., Early renal function deterioration is the only predictive factor of graft failure after 1 year, TRANSPLAN P, 32(2), 2000, pp. 425-426
Authors:
Vanrenterghem, Y
Lebranchu, Y
Hene, R
Oppenheimer, F
Ekberg, H
Citation: Y. Vanrenterghem et al., Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection, TRANSPLANT, 70(9), 2000, pp. 1352-1359
Authors:
Kreis, H
Cisterne, JM
Land, W
Wramner, L
Squifflet, JP
Abramowicz, D
Campistol, JM
Morales, JM
Grinyo, JM
Mourad, G
Berthoux, FC
Brattstrom, C
Lebranchu, Y
Vialtel, P
Citation: H. Kreis et al., Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients, TRANSPLANT, 69(7), 2000, pp. 1252-1260
Authors:
Khalfoun, B
Barrat, D
Watier, H
Machet, MC
Arbeille-Brassart, B
Riess, JG
Salmon, H
Gruel, Y
Bardos, P
Lebranchu, Y
Citation: B. Khalfoun et al., Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactions, SURGERY, 128(3), 2000, pp. 447-457
Authors:
Iochmann, S
Reverdiau-Moalic, P
Beaujean, S
Rideau, E
Lebranchu, Y
Bardos, P
Gruel, Y
Citation: S. Iochmann et al., Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription polymerase chain reaction, THROMB RES, 94(3), 1999, pp. 165-173
Citation: Y. Lebranchu, Comparison of two corticosteroid regimens in combination with CellCept andcyclosporine A for prevention of acute allograft rejection: 12 month results of a double-blind, randomized, multi-center study, TRANSPLAN P, 31(1-2), 1999, pp. 249-250
Authors:
Halimi, JM
Al-Najjar, A
Buchler, M
Birmele, B
Tranquart, F
Alison, D
Lebranchu, Y
Citation: Jm. Halimi et al., Transplant renal artery stenosis: Potential role of ischemia/reperfusion injury and long-term outcome following angioplasty, J UROL, 161(1), 1999, pp. 28-32
Authors:
Khalfoun, B
Sibue, D
Bardos, P
Lebranchu, Y
Citation: B. Khalfoun et al., Docosahexaenoic and eicosapentaenoic acids inhibit the CD28-lymphocyte activation pathway in vitro, TRANSPLAN P, 30(8), 1998, pp. 3978-3979
Authors:
Reverdiau-Moalic, P
Watier, H
Iochmann, S
Pouplard, C
Rideau, E
Lebranchu, Y
Bardos, P
Gruel, Y
Citation: P. Reverdiau-moalic et al., Human allogeneic lymphocytes trigger endothelial cell tissue factor expression by a tumor necrosis factor-dependent pathway, J LA CL MED, 132(6), 1998, pp. 530-540